"When pharmaceutical giant Merck & Co. abruptly pulled its arthritis pain medication Vioxx from the marketplace on Sept. 30, more than 2 million patients were taking the drug. Until then, they likely didn't know that the medicine designed to lower their risk of stomach bleeding also doubled the risk of heart attacks and stroke."
"But officials at Merck had suspected as much for at least four years." [The Southern Illinoisan - Editorial]
